J. A. Kroes Et Al. , "Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis," ERJ Open Research , vol.9, no.2, 2023
Kroes, J. A. Et Al. 2023. Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis. ERJ Open Research , vol.9, no.2 .
Kroes, J. A., Alfonso-Cristancho, R., Bansal, A. T., Berret, E., Bieksiene, K., Bourdin, A., ... Brussino, L.(2023). Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis. ERJ Open Research , vol.9, no.2.
Kroes, Johannes Et Al. "Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis," ERJ Open Research , vol.9, no.2, 2023
Kroes, Johannes A. Et Al. "Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis." ERJ Open Research , vol.9, no.2, 2023
Kroes, J. A. Et Al. (2023) . "Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis." ERJ Open Research , vol.9, no.2.
@article{article, author={Johannes A. Kroes Et Al. }, title={Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis}, journal={ERJ Open Research}, year=2023}